Kehamilan Spontan Pada Wanita 26 Tahun Dengan Riwayat Mucinous Cystadenoma Ovarii Papiler Borderline Malignancy Dan Pasca Kemoterapi
Article Sidebar
Submitted
4 August 2023
Published
31 August 2023
Keywords:
-
borderline malignancy, chemotherapy, conservative surgical staging
Abstract
Ovarian carcinoma is one of the most common gynecological cancers in women, third ranking after cervical uterine carcinoma and endometrial carcinoma. In this case a G1P0A0 woman aged 26 years pregnant 39 weeks 2 days with a history of dextra salphingooferectomy in 2016 with hitopathological results of mucinous cystadenoma ovarii papillary borderline malignancy and post chemotherapy. Surgery and chemotherapy therapy can impair fertility by affecting the nervous system or reproductive organs. Conservative surgical therapy (conservative surgical staging) and selection of appropriate chemotherapeutic agents can restore fertility in patients with borderline malignancy.
References
Momenimovahed, Z., Tiznobaik, A., Taheri, S., & Salehiniya, H. (2019). Ovarian cancer in the world: Epidemiology and risk factors. International Journal of Women’s Health, 11, 287–299. https://doi.org/10.2147/IJWH.S197604
A Babaier P Ghatage. (2020). Mucinous Cancer of the Ovary : Overview and Current Status. Diagnostics MDPI, 10(52), 1–16. https://doi.org/10.3390/diagnostics10010052
Cortez, A. J., Tudrej, P., Kujawa, K. A., & Lisowska, K. M. (2018). Advances in ovarian cancer therapy. Cancer Chemotherapy and Pharmacology, 81(1), 17–38. https://doi.org/10.1007/s00280-017-3501-8
Waimey, K. E., Smith, B. M., Confino, R., Jeruss, J. S., & Pavone, M. E. (2015). Understanding Fertility in Young Female Cancer Patients. Journal of Women’s Health, 24(10), 812–818. https://doi.org/10.1089/jwh.2015.5194
Daniela Fischerova, Michal Zikan, Pavel Dundr, D. C. (2012). Oncologist G. The Oncologist Express, 17(1), 1051–1062. https://doi.org/10.1634/theoncologist.2011-0227
Putu Ratna Darmayani, H. S. (2019). SEROMUCINOUS CARCINOMA OVARY. Angewandte Chemie International Edition, 6(11), 951–952., 3(1), 5–24
Spears, N., Lopes, F., Stefansdottir, A., Rossi, V., De Felici, M., Anderson, R. A., & Klinger, F. G. (2019). Ovarian damage from chemotherapy and current approaches to its protection. Human Reproduction Update, 25(6), 673–693. https://doi.org/10.1093/humupd/dmz027
Poorvu, P. D., Frazier, A. L., Feraco, A. M., Manley, P. E., Ginsburg, E. S., Laufer, M. R., LaCasce, A. S., Diller, L. R., & Partridge, A. H. (2019). Cancer treatment-related infertility: A critical review of the evidence. JNCI Cancer Spectrum, 3(1), 1–14. https://doi.org/10.1093/jncics/pkz008
Dasari, S., & Bernard Tchounwou, P. (2014). Cisplatin in cancer therapy: Molecular mechanisms of action. European Journal of Pharmacology, 740, 364–378. https://doi.org/10.1016/j.ejphar.2014.07.025
Taylan, E., & Oktay, K. (2019). Fertility preservation in gynecologic cancers. Gynecologic Oncology, 155(3), 522–529. https://doi.org/10.1016/j.ygyno.2019.09.012
Cömert, D. K., Üreyen, I., Karalok, A., Taşçı, T., Türkmen, O., Öcalan, R., Turan, T., & Tulunay, G. (2016). Mucinous borderline ovarian tumors: Analysis of 75 patients from a single center. Journal of the Turkish German Gynecology Association, 17(2), 96–100. https://doi.org/10.5152/jtgga.2016.15208
Wasnik, A. P., Menias, C. O., Platt, J., & Bedi, D. (2013). Multimodality imaging of ovarian cystic lesions: Review with an imaging based algorithmic approach. March. https://doi.org/10.4329/wjr.v5.i3.113
A Babaier P Ghatage. (2020). Mucinous Cancer of the Ovary : Overview and Current Status. Diagnostics MDPI, 10(52), 1–16. https://doi.org/10.3390/diagnostics10010052
Cortez, A. J., Tudrej, P., Kujawa, K. A., & Lisowska, K. M. (2018). Advances in ovarian cancer therapy. Cancer Chemotherapy and Pharmacology, 81(1), 17–38. https://doi.org/10.1007/s00280-017-3501-8
Waimey, K. E., Smith, B. M., Confino, R., Jeruss, J. S., & Pavone, M. E. (2015). Understanding Fertility in Young Female Cancer Patients. Journal of Women’s Health, 24(10), 812–818. https://doi.org/10.1089/jwh.2015.5194
Daniela Fischerova, Michal Zikan, Pavel Dundr, D. C. (2012). Oncologist G. The Oncologist Express, 17(1), 1051–1062. https://doi.org/10.1634/theoncologist.2011-0227
Putu Ratna Darmayani, H. S. (2019). SEROMUCINOUS CARCINOMA OVARY. Angewandte Chemie International Edition, 6(11), 951–952., 3(1), 5–24
Spears, N., Lopes, F., Stefansdottir, A., Rossi, V., De Felici, M., Anderson, R. A., & Klinger, F. G. (2019). Ovarian damage from chemotherapy and current approaches to its protection. Human Reproduction Update, 25(6), 673–693. https://doi.org/10.1093/humupd/dmz027
Poorvu, P. D., Frazier, A. L., Feraco, A. M., Manley, P. E., Ginsburg, E. S., Laufer, M. R., LaCasce, A. S., Diller, L. R., & Partridge, A. H. (2019). Cancer treatment-related infertility: A critical review of the evidence. JNCI Cancer Spectrum, 3(1), 1–14. https://doi.org/10.1093/jncics/pkz008
Dasari, S., & Bernard Tchounwou, P. (2014). Cisplatin in cancer therapy: Molecular mechanisms of action. European Journal of Pharmacology, 740, 364–378. https://doi.org/10.1016/j.ejphar.2014.07.025
Taylan, E., & Oktay, K. (2019). Fertility preservation in gynecologic cancers. Gynecologic Oncology, 155(3), 522–529. https://doi.org/10.1016/j.ygyno.2019.09.012
Cömert, D. K., Üreyen, I., Karalok, A., Taşçı, T., Türkmen, O., Öcalan, R., Turan, T., & Tulunay, G. (2016). Mucinous borderline ovarian tumors: Analysis of 75 patients from a single center. Journal of the Turkish German Gynecology Association, 17(2), 96–100. https://doi.org/10.5152/jtgga.2016.15208
Wasnik, A. P., Menias, C. O., Platt, J., & Bedi, D. (2013). Multimodality imaging of ovarian cystic lesions: Review with an imaging based algorithmic approach. March. https://doi.org/10.4329/wjr.v5.i3.113
Authors
Aryani, R., & Almas Nadifa. (2023). Kehamilan Spontan Pada Wanita 26 Tahun Dengan Riwayat Mucinous Cystadenoma Ovarii Papiler Borderline Malignancy Dan Pasca Kemoterapi. Journal of Midwifery and Health Science of Sultan Agung, 2(2), 37–44. Retrieved from https://mail.jmhsa.id/index.php/jmhsa/article/view/43
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.